Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Non-cash Items (2019 - 2024)

Historic Non-cash Items for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Q4 2024 value amounting to $5.0 million.

  • Arcturus Therapeutics Holdings' Non-cash Items fell 9065.0% to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 9065.0%. This contributed to the annual value of $5.0 million for FY2024, which is 9065.0% down from last year.
  • Arcturus Therapeutics Holdings' Non-cash Items amounted to $5.0 million in Q4 2024, which was down 9065.0% from $53.3 million recorded in Q4 2023.
  • Arcturus Therapeutics Holdings' Non-cash Items' 5-year high stood at $59.4 million during Q4 2020, with a 5-year trough of $5.0 million in Q4 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' median Non-cash Items value was $47.1 million (recorded in 2021), while the average stood at $35.1 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Non-cash Items skyrocketed by 1012980.89% in 2020 and then tumbled by 9065.0% in 2024.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Non-cash Items stood at $59.4 million in 2020, then fell by 20.75% to $47.1 million in 2021, then tumbled by 77.24% to $10.7 million in 2022, then surged by 397.11% to $53.3 million in 2023, then crashed by 90.65% to $5.0 million in 2024.
  • Its Non-cash Items stands at $5.0 million for Q4 2024, versus $53.3 million for Q4 2023 and $10.7 million for Q4 2022.